Thomas Thum
#109,719
Most Influential Person Now
Researcher
Thomas Thum's AcademicInfluence.com Rankings
Thomas Thumengineering Degrees
Engineering
#3123
World Rank
#4149
Historical Rank
Electrical Engineering
#638
World Rank
#700
Historical Rank
Thomas Thumcomputer-science Degrees
Computer Science
#4104
World Rank
#4320
Historical Rank
Computational Linguistics
#328
World Rank
#333
Historical Rank
Machine Learning
#708
World Rank
#718
Historical Rank
Artificial Intelligence
#907
World Rank
#924
Historical Rank
Download Badge
Engineering Computer Science
Thomas Thum's Degrees
- PhD Computer Science Stanford University
- Masters Electrical Engineering University of California, Berkeley
- Bachelors Computer Engineering University of California, Berkeley
Similar Degrees You Can Earn
Why Is Thomas Thum Influential?
(Suggest an Edit or Addition)Thomas Thum's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (2012) (2913)
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts (2008) (2253)
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches. (2016) (1212)
- MicroRNAs in the Human Heart: A Clue to Fetal Gene Reprogramming in Heart Failure (2007) (954)
- Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 (2021) (811)
- Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy. (2014) (767)
- LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. (2000) (512)
- Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency FERRIC-HF: a randomized, controlled, observer-blinded trial. (2007) (508)
- Regulation and function of miRNA-21 in health and disease (2011) (500)
- The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy (2012) (493)
- Circulating Long Noncoding RNA, LIPCAR, Predicts Survival in Patients With Heart Failure (2014) (447)
- MicroRNA-24 Regulates Vascularity After Myocardial Infarction (2011) (394)
- Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. (2011) (393)
- Exosomes: new players in cell-cell communication. (2012) (387)
- Endothelial Nitric Oxide Synthase Uncoupling Impairs Endothelial Progenitor Cell Mobilization and Function in Diabetes (2007) (385)
- MicroRNAs: novel regulators in cardiac development and disease. (2008) (363)
- The Circulating Long Non-Coding RNA LIPCAR Predicts Survival in Heart Failure Patients (2014) (340)
- Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. (2015) (337)
- Long noncoding RNA Chast promotes cardiac remodeling (2016) (304)
- Age-Dependent Impairment of Endothelial Progenitor Cells Is Corrected by Growth Hormone Mediated Increase of Insulin-Like Growth Factor-1 (2007) (290)
- Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury. (2017) (287)
- Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of Cardiovascular Disease (2010) (285)
- Long noncoding RNAs in cardiac development and ageing (2015) (285)
- Long noncoding RNAs in kidney and cardiovascular diseases (2016) (271)
- Myocardial fibrosis: biomedical research from bench to bedside (2017) (253)
- Suppression of endothelial progenitor cells in human coronary artery disease by the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine. (2005) (245)
- Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. (2018) (242)
- A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction (2013) (240)
- Transforming Growth Factor-&bgr;–Induced Endothelial-to-Mesenchymal Transition Is Partly Mediated by MicroRNA-21 (2012) (238)
- Inhibition of the Cardiac Fibroblast–Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction (2017) (233)
- Non-coding RNAs in cardiac remodeling and heart failure. (2013) (232)
- Role of miR-21 in the pathogenesis of atrial fibrosis (2012) (229)
- MicroRNA-21: from cancer to cardiovascular disease. (2010) (227)
- Effects of physical exercise on myocardial telomere-regulating proteins, survival pathways, and apoptosis. (2008) (225)
- Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension (2008) (223)
- Macrophage MicroRNA-155 Promotes Cardiac Hypertrophy and Failure (2013) (221)
- MicroRNAs as mediators and therapeutic targets in chronic kidney disease (2011) (204)
- MiR-378 Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated Protein Kinase Pathway Factors (2013) (195)
- Gene expression in distinct regions of the heart (2000) (195)
- Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. (2011) (195)
- MicroRNA therapeutics in cardiovascular medicine (2012) (191)
- Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy. (2016) (188)
- Urinary miR‐210 as a Mediator of Acute T‐Cell Mediated Rejection in Renal Allograft Recipients (2011) (187)
- The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. (2005) (186)
- Short Communication: Asymmetric Dimethylarginine Impairs Angiogenic Progenitor Cell Function in Patients With Coronary Artery Disease Through a MicroRNA-21–Dependent Mechanism (2010) (185)
- Circulating micrornas as potential biomarkers of aerobic exercise capacity (2013) (182)
- MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure (2015) (172)
- The continuous heart failure spectrum: moving beyond an ejection fraction classification. (2019) (170)
- Biogenesis and Regulation of Cardiovascular MicroRNAs (2011) (169)
- RNA-based diagnostic and therapeutic strategies for cardiovascular disease (2019) (167)
- Noncoding RNAs and myocardial fibrosis (2014) (166)
- Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio‐Oncology Council of the European Society of Cardiology (ESC) (2020) (165)
- Hallmarks of ion channel gene expression in end‐stage heart failure (2003) (158)
- Quaking Inhibits Doxorubicin-Mediated Cardiotoxicity Through Regulation of Cardiac Circular RNA Expression (2017) (157)
- Towards better definition, quantification and treatment of fibrosis in heart failure. A scientific roadmap by the Committee of Translational Research of the Heart Failure Association (HFA) of the European Society of Cardiology (2019) (155)
- SERCA2a gene therapy restores microRNA-1 expression in heart failure via an Akt/FoxO3A-dependent pathway (2012) (154)
- Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. (2014) (153)
- MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart (2012) (151)
- miR-212 and miR-132 are required for epithelial stromal interactions necessary for mouse mammary gland development (2010) (151)
- Circular RNAs in heart failure (2017) (148)
- Regulated microRNAs in the CSF of patients with multiple sclerosis (2012) (145)
- Endogenous Nitric Oxide Synthesis Inhibitor Asymmetric Dimethyl l-Arginine Accelerates Endothelial Cell Senescence (2004) (144)
- Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling (2017) (140)
- Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure (2013) (140)
- Testosterone, cytochrome P450, and cardiac hypertrophy (2002) (137)
- Therapeutic miR-21 Silencing Ameliorates Diabetic Kidney Disease in Mice. (2017) (135)
- Resveratrol Reverses Endothelial Nitric-Oxide Synthase Uncoupling in Apolipoprotein E Knockout Mice (2010) (133)
- Signal transducer and activator of transcription 3-mediated regulation of miR-199a-5p links cardiomyocyte and endothelial cell function in the heart: a key role for ubiquitin-conjugating enzymes. (2011) (132)
- Impairment of Wound Healing in Patients With Type 2 Diabetes Mellitus Influences Circulating MicroRNA Patterns via Inflammatory Cytokines (2015) (131)
- Circular RNAs: A Novel Class of Functional RNA Molecules with a Therapeutic Perspective. (2019) (129)
- Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus. (2008) (128)
- Diabetes-associated microRNAs in pediatric patients with type 1 diabetes mellitus: a cross-sectional cohort study. (2014) (126)
- Expression of Xenobiotic Metabolizing Enzymes in Different Lung Compartments of Smokers and Nonsmokers (2006) (124)
- Osteopontin is indispensible for AP1-mediated angiotensin II-related miR-21 transcription during cardiac fibrosis (2015) (123)
- Epigenetic modifications in cardiovascular disease (2012) (123)
- Bone marrow molecular alterations after myocardial infarction: Impact on endothelial progenitor cells. (2006) (121)
- Comparison of different miR-21 inhibitor chemistries in a cardiac disease model. (2011) (120)
- A phenotypic screen to identify hypertrophy-modulating microRNAs in primary cardiomyocytes. (2012) (119)
- MicroRNA-24 antagonism prevents renal ischemia reperfusion injury. (2014) (116)
- MicroRNAs in Hypertension: Mechanisms and Therapeutic Targets (2012) (116)
- Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study (2020) (114)
- European Society of Cardiology/Heart Failure Association position paper on the role and safety of new glucose‐lowering drugs in patients with heart failure (2019) (114)
- Circulating long-non coding RNAs as biomarkers of left ventricular diastolic function and remodelling in patients with well-controlled type 2 diabetes (2016) (114)
- Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase Enhancer AVE9488 After Experimental Myocardial Infarction (2008) (113)
- Searching for new mechanisms of myocardial fibrosis with diagnostic and/or therapeutic potential (2015) (110)
- Circulating long noncoding RNATapSaki is a predictor of mortality in critically ill patients with acute kidney injury. (2014) (107)
- SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications (2020) (107)
- Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart (2017) (106)
- MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs. (2014) (106)
- Development of Long Noncoding RNA-Based Strategies to Modulate Tissue Vascularization (2015) (105)
- Circulating miR-133a and miR-423-5p fail as biomarkers for left ventricular remodeling after myocardial infarction. (2013) (103)
- Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology (2021) (102)
- microRNA therapeutics in cardiovascular disease models. (2014) (101)
- The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC (2018) (101)
- miRNA screening reveals a new miRNA family stimulating iPS cell generation via regulation of Meox2 (2011) (96)
- Letter by Thum et al regarding article, "Oxidant stress impairs in vivo reendothelialization capacity of endothelial progenitor cells from patients with type 2 diabetes mellitus: restoration by the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone". (2008) (95)
- Preclinical development of a miR-132 inhibitor for heart failure treatment (2020) (94)
- Targeting myocardial remodelling to develop novel therapies for heart failure (2014) (94)
- Preclinical and Clinical Development of Noncoding RNA Therapeutics for Cardiovascular Disease (2020) (92)
- Cardiovascular Importance of the MicroRNA‐23/27/24 Family (2012) (92)
- Molecular diagnosis of a familial nonhemolytic hyperbilirubinemia (Gilbert's syndrome) in healthy subjects (2000) (91)
- Circulating and urinary microRNAs in kidney disease. (2012) (90)
- SLC26A9-mediated chloride secretion prevents mucus obstruction in airway inflammation. (2012) (89)
- Long Non-coding RNAs: At the Heart of Cardiac Dysfunction? (2019) (89)
- Critical role of the nitric oxide/reactive oxygen species balance in endothelial progenitor dysfunction. (2011) (86)
- Sodium–glucose co‐transporter 2 inhibitors in heart failure: beyond glycaemic control. A position paper of the Heart Failure Association of the European Society of Cardiology (2020) (85)
- Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) (84)
- Blood-based microRNA signatures differentiate various forms of cardiac hypertrophy. (2015) (84)
- MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma (2015) (83)
- Preclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction. (2016) (83)
- Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease. (2007) (83)
- An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology (2018) (81)
- Circulating cardiovascular microRNAs in critically ill COVID‐19 patients (2021) (80)
- MicroRNAs play a role in spontaneous recovery from acute liver failure (2014) (78)
- Glucocorticoid Insensitivity at the Hypoxic Blood–Brain Barrier Can Be Reversed by Inhibition of the Proteasome (2011) (75)
- Complex roads from genotype to phenotype in dilated cardiomyopathy: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology (2018) (73)
- Cellular dedifferentiation of endothelium is linked to activation and silencing of certain nuclear transcription factors: implications for endothelial dysfunction and vascular biology (2000) (72)
- Novel techniques and targets in cardiovascular microRNA research. (2012) (72)
- Vascular importance of the miR-212/132 cluster. (2014) (72)
- Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells (2019) (71)
- MicroRNAs in Myocardial Infarction (2013) (71)
- Mechanistic Role of Cytochrome P450 Monooxygenases in Oxidized Low-Density Lipoprotein–Induced Vascular Injury: Therapy Through LOX-1 Receptor Antagonism? (2004) (71)
- MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes (2020) (70)
- Cardiac myocyte-secreted cAMP exerts paracrine action via adenosine receptor activation. (2014) (69)
- Heart Failure Association of the European Society of Cardiology update on sodium–glucose co‐transporter 2 inhibitors in heart failure (2020) (69)
- MicroRNAs in diabetes and diabetes-associated complications (2012) (68)
- Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. (2007) (67)
- Clostridium difficile Toxin A Induces Expression of the Stress-induced Early Gene Product RhoB* (2005) (67)
- Regulatory RNAs and paracrine networks in the heart. (2014) (66)
- Circulating microRNAs and Outcome in Patients with Acute Heart Failure (2015) (66)
- miR-21 promotes fibrosis in an acute cardiac allograft transplantation model. (2016) (66)
- Plasma circular RNA hsa_circ_0001445 and coronary artery disease: Performance as a biomarker (2020) (66)
- Long Noncoding RNAs in Urine Are Detectable and May Enable Early Detection of Acute T Cell-Mediated Rejection of Renal Allografts. (2015) (65)
- Attenuated palmitoylation of serotonin receptor 5-HT1A affects receptor function and contributes to depression-like behaviors (2019) (65)
- LOX-1 Receptor Blockade Abrogates oxLDL-induced Oxidative DNA Damage and Prevents Activation of the Transcriptional Repressor Oct-1 in Human Coronary Arterial Endothelium* (2008) (65)
- Cytochrome P450 mono‐oxygenase gene expression and protein activity in cultures of adult cardiomyocytes of the rat (2000) (64)
- Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I. (2007) (64)
- Long Noncoding RNA-Enriched Vesicles Secreted by Hypoxic Cardiomyocytes Drive Cardiac Fibrosis (2019) (63)
- AntimiR-21 Prevents Myocardial Dysfunction in a Pig Model of Ischemia/Reperfusion Injury. (2020) (63)
- Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury (2018) (61)
- Common mechanistic pathways in cancer and heart failure. A scientific roadmap on behalf of the Translational Research Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC) (2020) (61)
- Microvesicles as Novel Biomarkers and Therapeutic Targets in Transplantation Medicine (2012) (60)
- Review focus on the role of microRNA in cardiovascular biology and disease. (2012) (60)
- MicroRNAs and vascular (dys)function. (2011) (60)
- Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy (2021) (59)
- Regulation of cardiac and renal ischemia-reperfusion injury by microRNAs. (2013) (59)
- Circulating non-coding RNAs in biomarker-guided cardiovascular therapy: a novel tool for personalized medicine? (2018) (59)
- Impairment of endothelial progenitor cell function and vascularization capacity by aldosterone in mice and humans (2010) (59)
- Antiandrogenic Therapy With Finasteride Attenuates Cardiac Hypertrophy and Left Ventricular Dysfunction (2015) (59)
- Growth hormone induces eNOS expression and nitric oxide release in a cultured human endothelial cell line (2003) (58)
- Activation of the miR-17 family and miR-21 during murine kidney ischemia-reperfusion injury. (2013) (57)
- Inflammatory cells and their non-coding RNAs as targets for treating myocardial infarction (2018) (55)
- Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy (2020) (55)
- Chronic miR‐29 antagonism promotes favorable plaque remodeling in atherosclerotic mice (2016) (55)
- Circulating miR-423_5p fails as a biomarker for systemic ventricular function in adults after atrial repair for transposition of the great arteries. (2013) (55)
- MicroRNA-Mediated Epigenetic Silencing of Sirtuin1 Contributes to Impaired Angiogenic Responses (2013) (54)
- Noncoding RNAs as regulators of cardiomyocyte proliferation and death. (2015) (53)
- Circulating microRNA‐132 levels improve risk prediction for heart failure hospitalization in patients with chronic heart failure (2018) (53)
- Adrenergic Repression of the Epigenetic Reader MeCP2 Facilitates Cardiac Adaptation in Chronic Heart Failure (2015) (53)
- Circulating microRNAs for predicting and monitoring response to mechanical circulatory support from a left ventricular assist device (2014) (52)
- TWIST1 regulates the activity of ubiquitin proteasome system via the miR-199/214 cluster in human end-stage dilated cardiomyopathy. (2013) (50)
- Circulating MicroRNAs Are Not Eliminated by Hemodialysis (2012) (50)
- MicroRNAs in platelet biogenesis and function (2012) (49)
- RNA Profiling in Human and Murine Transplanted Hearts: Identification and Validation of Therapeutic Targets for Acute Cardiac and Renal Allograft Rejection (2015) (49)
- Circulating miRNAs as mediators in cell-to-cell communication. (2019) (48)
- CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure (2020) (48)
- Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology (2018) (48)
- No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. (2009) (48)
- Intercellular communication lessons in heart failure (2015) (47)
- Deciphering the microRNA signature of pathological cardiac hypertrophy by engineered heart tissue- and sequencing-technology. (2015) (45)
- Podocytes regulate the glomerular basement membrane protein nephronectin by means of miR-378a-3p in glomerular diseases. (2017) (45)
- Toward standardization of echocardiography for the evaluation of left ventricular function in adult rodents: a position paper of the ESC Working Group on Myocardial Function. (2020) (45)
- Stiff matrix induces switch to pure β-cardiac myosin heavy chain expression in human ESC-derived cardiomyocytes (2016) (45)
- Endothelial progenitor cells in pulmonary arterial hypertension. (2010) (45)
- Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification. (2015) (45)
- Therapeutic and Diagnostic Translation of Extracellular Vesicles in Cardiovascular Diseases (2021) (45)
- Functional microRNA library screening identifies the hypoxamir miR-24 as a potent regulator of smooth muscle cell proliferation and vascularization. (2014) (45)
- Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid Leukemia. (2018) (44)
- Proteomic Bioprofiles and Mechanistic Pathways of Progression to Heart Failure. (2019) (44)
- Non-coding RNAs as modulators of the cardiac fibroblast phenotype. (2016) (44)
- Differential Effects of Organic Nitrates on Endothelial Progenitor Cells Are Determined by Oxidative Stress (2007) (43)
- Induction of nuclear transcription factors, cytochrome P450 monooxygenases, and glutathione S-transferase alpha gene expression in Aroclor 1254-treated rat hepatocyte cultures. (2001) (42)
- Sonic hedgehog-dependent activation of adventitial fibroblasts promotes neointima formation (2017) (41)
- Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high‐risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of Cardiology (2020) (40)
- MicroRNA-Based Therapy of GATA2-Deficient Vascular Disease (2016) (39)
- Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy (2019) (39)
- MicroRNAs as circulating biomarkers for heart failure: questions about MiR-423-5p. (2010) (38)
- Noncoding RNAs in Heart Failure. (2016) (38)
- Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation (2016) (37)
- Omics phenotyping in heart failure: the next frontier. (2020) (37)
- Long Noncoding RNAs in Pathological Cardiac Remodeling. (2017) (37)
- Non-coding RNAs in cardiovascular ageing (2014) (37)
- LINCing MALAT1 and angiogenesis. (2014) (36)
- Non-coding RNAs: emerging players in cardiomyocyte proliferation and cardiac regeneration (2020) (36)
- Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease. (2012) (35)
- Increased Proangiogenic Activity of Mobilized CD34+ Progenitor Cells of Patients With Acute ST-Segment–Elevation Myocardial Infarction: Role of Differential MicroRNA-378 Expression (2017) (35)
- Deregulation of microRNA-181c in cerebrospinal fluid of patients with clinically isolated syndrome is associated with early conversion to relapsing–remitting multiple sclerosis (2016) (34)
- Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction (2020) (34)
- Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356 (2016) (33)
- Non-coding RNAs - Update on mechanisms and therapeutic targets from the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. (2020) (33)
- Differential effects of organic nitrates on endothelial progenitor cells are determined by oxidative stress. (2007) (33)
- Metabolism of verapamil: 24 new phase I and phase II metabolites identified in cell cultures of rat hepatocytes by liquid chromatography-tandem mass spectrometry. (2003) (33)
- Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension (2017) (33)
- Aromatase Inhibition Attenuates Desflurane-Induced Preconditioning against Acute Myocardial Infarction in Male Mouse Heart In Vivo (2012) (32)
- Zinc-α2-Glycoprotein Exerts Antifibrotic Effects in Kidney and Heart. (2015) (32)
- miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity. (2019) (32)
- MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy (2017) (31)
- Editorial :Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). DOI: 10.1080/15548627.2015.1100356;WOS:000373595400001; 2-s2.0-85013763791&;PMID: 26799652 (2016) (31)
- Renal AAV2-Mediated Overexpression of Long Non-Coding RNA H19 Attenuates Ischemic Acute Kidney Injury Through Sponging of microRNA-30a-5p. (2021) (31)
- A rapid and simple CYP2D6 genotyping assay--case study with the analgetic tramadol. (2003) (30)
- Mitochondrial long noncoding RNAs as blood based biomarkers for cardiac remodeling in patients with hypertrophic cardiomyopathy. (2016) (30)
- Cardiac fibrosis revisited by microRNA therapeutics. (2012) (30)
- Circulating Long Noncoding RNA LIPCAR Predicts Heart Failure Outcomes in Patients Without Chronic Kidney Disease (2019) (29)
- MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2017) (29)
- Cardiac dysfunction in cancer patients: beyond direct cardiomyocyte damage of anticancer drugs. Novel cardio-oncology insights from the joint 2019 meeting of the ESC Working Groups of Myocardial Function and Cellular Biology of the Heart. (2020) (29)
- SARS-CoV-2 receptor ACE2 expression in the human heart: cause of a post-pandemic wave of heart failure? (2020) (29)
- Role of microRNAs in immunity and organ transplantation (2011) (29)
- MicroRNAs in right ventricular remodelling (2017) (28)
- GC-MS assay for hepatic DDAH activity in diabetic and non-diabetic rats by measuring dimethylamine (DMA) formed from asymmetric dimethylarginine (ADMA): evaluation of the importance of S-nitrosothiols as inhibitors of DDAH activity in vitro and in vivo in humans. (2007) (28)
- Bioinformatics of cardiovascular miRNA biology. (2015) (27)
- Verapamil: metabolism in cultures of primary human coronary arterial endothelial cells. (2003) (27)
- Detection of early signals of hepatotoxicity by gene expression profiling studies with cultures of metabolically competent human hepatocytes (2008) (26)
- Increase of pro-inflammatory cytokine expression in non-demyelinating early cerebral lesions in nervous canine distemper. (2008) (26)
- MiRNA‐181a is a novel regulator of aldosterone–mineralocorticoid receptor‐mediated cardiac remodelling (2020) (26)
- Non-coding RNAs in vascular disease – from basic science to clinical applications: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology (2018) (26)
- Verapamil: new insight into the molecular mechanism of drug oxidation in the human heart. (2002) (25)
- Verapamil: identification of novel metabolites in cultures of primary human hepatocytes and human urine by LC-MS n and LC-NMR (2003) (25)
- A large shRNA library approach identifies lncRNA Ntep as an essential regulator of cell proliferation (2017) (25)
- MicroRNAs in the bile of patients with biliary strictures after liver transplantation (2014) (25)
- Risk stratification and management of women with cardiomyopathy/heart failure planning pregnancy or presenting during/after pregnancy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on Peripartum Cardiomyopathy (2021) (25)
- Remote Welfare Monitoring of Rodents Using Thermal Imaging (2018) (25)
- Aroclor 1254 modulates gene expression of nuclear transcription factors: implications for albumin gene transcription and protein synthesis in rat hepatocyte cultures. (2002) (24)
- MicroRNAs in platelet physiology and pathology (2013) (24)
- COVID‐19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of Cardiology (2021) (24)
- MicroRNAs in the broken heart (2007) (24)
- New Insights Into miR-17-92 Cluster Regulation and Angiogenesis. (2016) (24)
- miRNAs involved in the generation, maintenance, and differentiation of pluripotent cells (2012) (24)
- AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction. (2021) (23)
- miRNome Profiling of Purified Endoderm and Mesoderm Differentiated from hESCs Reveals Functions of miR-483-3p and miR-1263 for Cell-Fate Decisions (2017) (23)
- Antagonism of profibrotic microRNA-21 improves outcome of murine chronic renal allograft dysfunction. (2017) (23)
- MicroRNAs in Right Ventricular (dys)function (2013 Grover Conference Series) (2014) (22)
- Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study (2018) (22)
- Rationale of the FIBROTARGETS study designed to identify novel biomarkers of myocardial fibrosis (2017) (22)
- PCBs alter gene expression of nuclear transcription factors and other heart-specific genes in cultures of primary cardiomyocytes: possible implications for cardiotoxicity (2002) (22)
- Cardiomyocyte ageing and cardioprotection: Consensus Document from the ESC Working Groups Cell Biology of the Heart and Myocardial Function. (2020) (21)
- TLR-4+ peripheral blood monocytes and cardiovascular events in patients with chronic kidney disease--a prospective follow-up study. (2011) (21)
- Non‐coding RNAs: key players in cardiac disease (2020) (21)
- Renal effects of guideline‐directed medical therapies in heart failure: a consensus document from the Heart Failure Association of the European Society of Cardiology (2022) (21)
- Endothelial function in contemporary patients with repaired coarctation of aorta (2014) (21)
- Non-coding RNAs as orchestrators of autophagic processes. (2016) (21)
- Telomerase therapy attenuates cardiotoxic effects of doxorubicin (2020) (20)
- Regulator of G-Protein Signaling 5 Prevents Smooth Muscle Cell Proliferation and Attenuates Neointima Formation (2015) (20)
- Circulating Long Noncoding RNAs in Personalized Medicine: Response to Pioglitazone Therapy in Type 2 Diabetes. (2016) (20)
- Blood-based microRNA profiling in patients with cardiac amyloidosis (2018) (20)
- Pharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics. (2020) (19)
- Novel biomarkers for acute myocardial infarction: is microRNA the new kid on the block? (2014) (19)
- Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies. (2021) (19)
- Living myocardial slices: a novel multicellular model for cardiac translational research (2019) (19)
- Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212 (2019) (19)
- miR-21, Mediator, and Potential Therapeutic Target in the Cardiorenal Syndrome (2020) (19)
- Selective Heart Irradiation Induces Cardiac Overexpression of the Pro-hypertrophic miR-212 (2019) (19)
- Heterocellular signalling and crosstalk in the heart in ischaemia and heart failure. (2014) (18)
- Association between Circular RNA CDR1as and Post-Infarction Cardiac Function in Pig Ischemic Heart Failure: Influence of the Anti-Fibrotic Natural Compounds Bufalin and Lycorine (2020) (18)
- Inhibition of miRNA-212/132 improves the reprogramming of fibroblasts into induced pluripotent stem cells by de-repressing important epigenetic remodelling factors. (2017) (18)
- Butanedione monoxime increases the viability and yield of adult cardiomyocytes in primary cultures (2007) (18)
- Identification of major CYP2C9 and CYP2C19 polymorphisms by fluorescence resonance energy transfer analysis. (2002) (18)
- Inflammatory Drivers of Cardiovascular Disease: Molecular Characterization of Senescent Coronary Vascular Smooth Muscle Cells (2020) (18)
- Microparticles and MicroRNAs of Endothelial Progenitor Cells Ameliorate AKI (2012) (18)
- Circulating microRNAs predispose to takotsubo syndrome following high-dose adrenaline exposure (2021) (18)
- Analytical approaches in microRNA therapeutics. (2014) (18)
- Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish (2018) (17)
- The smooth long noncoding RNA SENCR. (2014) (17)
- Endothelial progenitor cell dysfunction: mechanisms and therapeutic approaches (2007) (17)
- In peripartum cardiomyopathy Plasminogen Activator Inhibitor-1 is a potential new biomarker with controversial roles. (2019) (17)
- Cardiac dissonance without conductors: how dicer depletion provokes chaos in the heart. (2008) (17)
- Circulating microRNAs in Fabry Disease (2019) (16)
- Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: Consensus Document from the joint 2019 meeting of the ESC Working Groups of Cellular Biology of the heart and Myocardial Function. (2020) (16)
- Resident cardiac macrophages: crucial modulators of cardiac (patho)physiology (2020) (16)
- Endothelial progenitor cells as potential drug targets. (2005) (16)
- miR−21 and NT-proBNP Correlate with Echocardiographic Parameters of Atrial Dysfunction and Predict Atrial Fibrillation (2020) (16)
- A novel multi-parametric analysis of non-invasive methods to assess animal distress during chronic pancreatitis (2019) (16)
- A circular RNA derived from the insulin receptor locus protects against doxorubicin-induced cardiotoxicity (2022) (16)
- MicroRNA-based therapeutic approaches in the cardiovascular system. (2012) (15)
- The IGF-1 Receptor as a Therapeutic Target to Improve Endothelial Progenitor Cell Function (2008) (15)
- MicroRNA-based therapy in cardiology (2014) (15)
- Verapamil metabolism in distinct regions of the heart and in cultures of cardiomyocytes of adult rats. (2001) (15)
- Pathophysiology of Takotsubo syndrome – a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology – Part 1: overview and the central role for catecholamines and sympathetic nervous system (2021) (15)
- Androgen metabolism in thymus of fetal and adult rats. (2004) (14)
- Identification of miR‐126 as a new regulator of skin ageing (2017) (14)
- Skeletal muscle derived Musclin protects the heart during pathological overload (2022) (14)
- HFA/HFSA/JHFS Position Statement on Endomyocardial Biopsy. (2021) (14)
- Isolation and cultivation of Ca2+ tolerant cardiomyocytes from the adult rat: improvements and applications (2000) (14)
- Organic nitrates differentially modulate circulating endothelial progenitor cells and endothelial function in patients with symptomatic coronary artery disease. (2011) (14)
- MicroRNAs in vascular biology – metabolism and atherosclerosis (2012) (14)
- Enabling [(18)F]-bicyclo[6.1.0]nonyne for oligonucleotide conjugation for positron emission tomography applications: [(18)F]-anti-microRNA-21 as an example. (2015) (14)
- ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models (2014) (14)
- Identification of cardiovascular microRNA targetomes. (2011) (14)
- Breakthrough in cachexia treatment through a novel selective androgen receptor modulator?! (2011) (13)
- Noncoding RNAs: potential regulators in cardioncology. (2019) (13)
- Identification of cell and disease specific microRNAs in glomerular pathologies (2017) (13)
- Facts and updates about cardiovascular non‐coding RNAs in heart failure (2015) (13)
- REPROGRAMMING OF GENE EXPRESSION IN CULTURED CARDIOMYOCYTES AND IN EXPLANTED HEARTS BY THE MYOSIN ATPASE INHIBITOR BUTANEDIONE MONOXIME (2001) (13)
- Aging impairs alveolar epithelial type II cell function in acute lung injury. (2020) (13)
- Integrative Bioinformatic Analyses of Global Transcriptome Data Decipher Novel Molecular Insights into Cardiac Anti-Fibrotic Therapies (2020) (13)
- Microarray-based gene expression profiling to elucidate cellular responses to nitric oxide--a review from an analytical and biomedical point of view. (2007) (13)
- Cardiac remodelling – Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (13)
- Linc-ing the Noncoding Genome to Heart Function: Beating Hypertrophy. (2017) (13)
- Remodelling of adult cardiac tissue subjected to physiological and pathological mechanical load in vitro (2021) (12)
- Conversion from conventional in-centre thrice-weekly haemodialysis to short daily home haemodialysis ameliorates uremia-associated clinical parameters (2012) (12)
- Assessment of major mental disorders in a German peripartum cardiomyopathy cohort (2020) (12)
- Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC) (2021) (12)
- Cardiovascular RNA markers and artificial intelligence may improve COVID-19 outcome: a position paper from the EU-CardioRNA COST Action CA17129 (2021) (12)
- A 3D iPSC-differentiation model identifies interleukin-3 as a regulator of early human hematopoietic specification (2020) (12)
- TIP30 counteracts cardiac hypertrophy and failure by inhibiting translational elongation (2019) (12)
- Liraglutide for weight loss in obese people (2010) (11)
- Improved cardiovascular risk prediction in patients with end-stage renal disease on hemodialysis using machine learning modeling and circulating microribonucleic acids (2020) (11)
- Congestion in heart failure: a circulating biomarker‐based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology (2022) (11)
- miRNAGE-34 induces cardiac damAGE (2013) (11)
- Impact of a Met(11)Thr single nucleotide polymorphism of surfactant protein D on allergic airway inflammation in a murine asthma model (2014) (11)
- A practical guide for investigating cardiac physiology using living myocardial slices (2020) (11)
- Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion (2020) (10)
- Therapeutic modulation of RNA-binding protein Rbm38 facilitates re-endothelialization after arterial injury (2019) (10)
- Circulating miR-21 and miR-29a as Markers of Disease Severity and Etiology in Cholestatic Pediatric Liver Disease (2016) (10)
- Reciprocal organ interactions during heart failure: a position paper from the ESC Working Group on Myocardial Function (2021) (10)
- Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy (2021) (10)
- MiR-486 attenuates cardiac ischemia/reperfusion injury and mediates the beneficial effect of exercise for myocardial protection. (2022) (10)
- Growth hormone regulates vascular function—what we know from bench and bedside (2006) (10)
- Measurement and diagnostic use of hepatic cytochrome P450 metabolism of oleic acid in liver disease (2010) (10)
- Cardiac remodelling – Part 2: Clinical, imaging and laboratory findings. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology (2022) (10)
- Nutritional iron deficiency in patients with chronic illnesses (2007) (10)
- Novel aspects of age-protection by spermidine supplementation are associated with preserved telomere length (2021) (9)
- What are microRNAs (2014) (9)
- MicroRNA Target Sites as Genetic Tools to Enhance Promoter-Reporter Specificity for the Purification of Pancreatic Progenitor Cells from Differentiated Embryonic Stem Cells (2013) (9)
- Epigenetic modulation of vascular diseases: Assessing the evidence and exploring the opportunities. (2018) (9)
- Comprehensive Bioinformatics Identifies Key microRNA Players in ATG7-Deficient Lung Fibroblasts (2020) (9)
- Circulating microRNAs in Patients with Shiga-Toxin-Producing E. coli O104:H4 Induced Hemolytic Uremic Syndrome (2012) (9)
- State-of-the-art on non-coding RNA bioinformatics, diagnostics and therapeutics in cardiovascular diseases: Preface to SI Non-coding RNAs in cardiovascular disease. (2015) (9)
- Dissecting the transcriptome in cardiovascular disease (2021) (9)
- MiR-378 Controls Cardiac Hypertrophy by Combined Repression of MAP Kinase Pathway Factors (2013) (9)
- Leptin Expression and Gene Methylation Patterns in Alcohol-Dependent Patients with Ethyltoxic Cirrhosis—Normalization After Liver Transplantation and Implications for Future Research (2018) (8)
- miR-625-3p is upregulated in CD8+ T cells during early immune reconstitution after allogeneic stem cell transplantation (2017) (8)
- Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity (2018) (8)
- Genomic instability in the naturally and prematurely aged myocardium (2021) (8)
- Perspective review of optical imaging in welfare assessment in animal-based research (2019) (8)
- Inhibition of proteasome‐mediated glucocorticoid receptor degradation restores nitric oxide bioavailability in myocardial endothelial cells in vitro (2014) (8)
- Pathologic endothelial response and impaired function of circulating angiogenic cells in patients with Fabry disease (2012) (8)
- Effects of personalized endurance training on cellular age and vascular function in middle-aged sedentary women (2019) (8)
- LC-MS/MS and GC-MS/MS measurement of plasma and urine di-paracetamol and 3-nitro-paracetamol: proof-of-concept studies on a novel human model of oxidative stress based on oral paracetamol administration. (2014) (8)
- Cardiac endurance training alters plasma profiles of circular RNA MBOAT2. (2020) (8)
- Cardiac fibroblasts on the fast track--scleraxis: from Achilles' heel to anti-fibrotic therapy. (2009) (8)
- Elevated levels of miR-181c and miR-633 in the CSF of patients with MS (2019) (8)
- Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction. (2021) (7)
- Spotlight on endothelial progenitor cell inhibitors: short review (2005) (7)
- Changing Direction: From Therapeutic Telomerase Inhibition to Activation? (2017) (7)
- Cardiac Fibroblast Growth Factor 23 Excess Does Not Induce Left Ventricular Hypertrophy in Healthy Mice (2021) (7)
- Blood-based protein profiling identifies serum protein c-KIT as a novel biomarker for hypertrophic cardiomyopathy (2021) (7)
- Spotlight on endothelial progenitor cell inhibitors: short review (2005) (7)
- Non-coding RNAs: Regulators of valvular calcification. (2020) (7)
- Pleiotropic cardiac functions controlled by ischemia-induced lncRNA H19. (2020) (7)
- Combined high-throughput library screening and next generation RNA sequencing uncover microRNAs controlling human cardiac fibroblast biology. (2020) (7)
- ADMA, endothelial progenitor cells, and cardiovascular risk. (2005) (7)
- Non-coding RNAs in ageing (2014) (7)
- Identification of miR-143 as a Major Contributor for Human Stenotic Aortic Valve Disease (2019) (7)
- MicroRNAs in cardiac hypertrophy and failure (2008) (7)
- Alternative strategies in cardiac preclinical research and new clinical trial formats (2021) (6)
- CircSlc8a1, breaking a vicious circle in cardiac hypertrophy. (2019) (6)
- miR-21-KO Alleviates Alveolar Structural Remodeling and Inflammatory Signaling in Acute Lung Injury (2020) (6)
- 349 Hallmarks of ion channel gene expression in end-stage heart failure (2003) (6)
- Interpretation and actionability of genetic variants in cardiomyopathies: a position statement from the European Society of Cardiology Council on cardiovascular genomics. (2022) (6)
- DGK and DZHK position paper on genome editing: basic science applications and future perspective (2021) (6)
- Impact analysis of heart failure across European countries: an ESC‐HFA position paper (2022) (6)
- Long noncoding RNAs as inducers and terminators of vascular development. (2015) (6)
- New insight into healing mechanisms of the infarcted heart. (2010) (6)
- Novel non-coding RNA-based therapeutic approaches to prevent statin-induced liver damage (2012) (6)
- Circulating non-coding RNAs as biomarkers to predict and monitor the response to exercise: chances and hurdles. (2018) (6)
- ERBB4 and Multiple MicroRNAs That Target ERBB4 Participate in Pregnancy-Related Cardiomyopathy (2021) (6)
- Translational Opportunities and Challenges of Long Noncoding RNAs in Cardiac Regeneration. (2018) (5)
- Artificial Intelligence Identifies an Urgent Need for Peripheral Vascular Intervention by Multiplexing Standard Clinical Parameters (2021) (5)
- Obesity and risk of myocardial infarction: the INTERHEART study (2006) (5)
- Emerging epigenetic therapies of cardiac fibrosis and remodeling in heart failure: from basic mechanisms to early clinical development. (2022) (5)
- microRNA-206 correlates with left ventricular function after transcatheter aortic valve implantation. (2017) (5)
- Circulating miR-216a as a biomarker of metabolic alterations and obesity in women (2020) (5)
- Growth hormone treatment improves markers of systemic nitric oxide bioavailability via the insulin-like growth factor-1 Importance for endothelial progenitor cells. (2007) (5)
- Remote vitals monitoring in rodents using video recordings. (2019) (5)
- Role of endothelial microRNA 155 on capillary leakage in systemic inflammation (2021) (5)
- Trapping of NAPQI, the intermediate toxic paracetamol metabolite, by aqueous sulfide (S²⁻) and analysis by GC-MS/MS. (2014) (5)
- Long non-coding RNAs: A crucial part of the vasculature puzzle. (2019) (5)
- MicroRNAs associated with ischemia/reperfusion injury and (2014) (5)
- Tilarginine in patients with acute myocardial infarction and cardiogenic shock. (2007) (5)
- The Long Non-coding RNA Cyrano Is Dispensable for Pluripotency of Murine and Human Pluripotent Stem Cells (2020) (4)
- Identification of sex‐specific biomarkers predicting new‐onset heart failure (2021) (4)
- Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter‐defibrillator for primary prevention? (2022) (4)
- MicroRNA-223 made its way into vascular research. (2013) (4)
- Sports or statins for atheroprotection? New insight from Kruppel-like factor 2. (2006) (4)
- MicroRNAs as systemic biomarkers to assess distress in animal models for gastrointestinal diseases (2020) (4)
- Comprehensive Expression Analysis of Cardiac Fibroblast Growth Factor 23 in Health and Pressure-induced Cardiac Hypertrophy (2022) (4)
- Methods for the identification and characterization of extracellular vesicles in cardiovascular studies - from exosomes to microvesicles. (2022) (4)
- Serum microRNAs and antifibrotic response to eplerenone in acute myocardial infarction complicated by systolic dysfunction. (2021) (4)
- Limitations of gait speed as an independent predictor of mortality and morbidity in cardiac patients. (2011) (4)
- The long non-coding RNA NRON promotes the development of cardiac hypertrophy in the murine heart. (2021) (4)
- MicroRNAs in idiopathic childhood nephrotic syndrome. (2013) (4)
- Studying Interactions between 2’-O-Me-Modified Inhibitors and MicroRNAs Utilizing Microscale Thermophoresis (2019) (4)
- TISSUE INJURY AND REPAIR (2014) (4)
- Non-coding RNAs: key regulators of reprogramming, pluripotency, and cardiac cell specification with therapeutic perspective for heart regeneration (2021) (4)
- Cardiac regeneration by progenitor cells – bedside before bench? (2005) (4)
- TGF-β Inhibitor CILP as a Novel Biomarker for Cardiac Fibrosis∗ (2020) (4)
- Letter by Pinet et al Regarding Article, "Comparative Analysis of Circulating Noncoding RNAs Versus Protein Biomarkers in the Detection of Myocardial Injury". (2019) (4)
- Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function: simply effects of optimized drug treatment? (2005) (3)
- [Non-coding RNA : Innovative regulators with therapeutic perspective]. (2018) (3)
- A comprehensive method protocol for annotation and integrated functional understanding of lncRNAs (2019) (3)
- Reply to ‘COVID‐19 severity, miR‐21 targets, and common human genetic variation’ (2021) (3)
- Circulating Micrornas As Potential Biomarkers Of Aerobic Exercise: 2385 Board #90 May 30, 9 (2014) (3)
- Circulating miR-185-5p as a Potential Biomarker for Arrhythmogenic Right Ventricular Cardiomyopathy (2021) (3)
- Accelerating cardiovascular research: recent advances in translational 2D and 3D heart models (2022) (3)
- Biomarkers for the prediction of heart failure and cardiovascular events in patients with type 2 diabetes: a position statement from the Heart Failure Association of the European Society of Cardiology (2022) (3)
- MicroRNAs deciding cardiac stem cell fate. (2012) (3)
- Detection and transport mechanisms of circulating microRNAs in neurological, cardiac and kidney diseases. (2013) (3)
- Circulating microRNAs in Symptomatic and Asymptomatic Carotid Stenosis (2021) (2)
- MicroRNAs in cardiovascular disease — From disease mechanisms to therapeutic approaches (2012) (2)
- Development and characterization of anti-fibrotic natural compound similars with improved effectivity (2022) (2)
- LIPCAR Is Increased in Chronic Symptomatic HF Patients. A Sub-Study of the GISSI-HF Trial. (2021) (2)
- Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology (2022) (2)
- MicroRNAs: Novel Therapeutic Targets for Diabetic Wound Healing (2018) (2)
- Reconstruction of the miR-506-Quaking axis in Idiopathic Pulmonary Fibrosis using integrative multi-source bioinformatics (2021) (2)
- MicroRNAs looping around angiogenesis. (2011) (2)
- Nichtkodierende RNA (2017) (2)
- FO083CHRONIC FGF23 OVERLOAD FAILS TO INDUCE CARDIAC DYSFUNCTIONS (2019) (2)
- Reply letter to: Letter regarding the article 'Circulating cardiovascular microRNAs in critically ill COVID-19 patients'. (2021) (2)
- Recent patents on cardiovascular stem cells. (2008) (2)
- Absence of microRNA-155 protects against adverse cardiac inflammation and hypertrophy during pressure overload and prevents heart failure (2012) (2)
- Poster Session 2 (2009) (2)
- Exercise-Induced Long Noncoding RNAs As New Players in Cardiac Hypertrophy. (2022) (2)
- Pharmacokinetic Studies of Antisense Oligonucleotides Using MALDI-TOF Mass Spectrometry (2020) (2)
- P70Circulating microRNAs and outcome in patients with acute heart failure (2014) (1)
- Abstract 3752: Mineralocorticoid Receptor Antagonism Prevents Aldosterone Mediated Dysfunction of Human Endothelial Progenitor Cells in Vitro, in Vivo and in Patients (2008) (1)
- Corrigendum: Leptin Expression and Gene Methylation Patterns in Alcohol-Dependent Patients with Ethyltoxic Cirrhosis-Normalization After Liver Transplantation and Implications for Future Research. (2018) (1)
- Molecular Mechanisms of Takotsubo Syndrome (2022) (1)
- Hypoxia-Induced MicroRNA-212/132 Alter Blood-Brain Barrier Integrity Through Inhibition of Tight Junction-Associated Proteins in Human and Mouse Brain Microvascular Endothelial Cells (2019) (1)
- 584 Prevention of cardiac hypertrophy and failure in vivo by a novel microRNA antagonist (2008) (1)
- Porcine model of progressive cardiac hypertrophy and fibrosis with secondary postcapillary pulmonary hypertension (2017) (1)
- The BALANCE study too early to speculate on mortality effects. (2010) (1)
- MiR-142-3p is a paracrine mediator between T cells and endothelium during allograft rejection. (2017) (1)
- , Failure Circulating Long Noncoding RNA , LIPCAR , Predicts Survival in Patients With Heart (1)
- Exosomal MicroRNAs Released by Pediatric Cardiac Progenitor Cells. (2017) (1)
- 178 Circulating Micrornas for Predicting and Monitoring Response to Mechanical Circulatory Support from a left Ventricular Assist Device (2014) (1)
- Prognostic value of circulating microRNAs compared to high-sensitivity troponin T in patients presenting with suspected acute coronary syndrome to the emergency department. (2021) (1)
- Inotropic therapy in patients with advanced heart failure. A clinical consensus statement from the Heart Failure Association of the European Society of Cardiology (2023) (1)
- Identification of MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy (CAV) (2014) (1)
- Supplementary Information: Enabling [18F]-bicyclo[6.1.0]nonyne for oligonucleotide conjugation for positron emission tomography applications: [18F]-anti-microRNA-21 as an example (2015) (1)
- Abstract 251: miRNA Mapping of Cardiac Endothelial and Fibroblast Cells during Hypertrophy Progression (2018) (1)
- MicroRNA and disease models: focus on cardiac fibrosis (2013) (1)
- Cardiac device wearers should keep distance from smartphones. (2015) (1)
- Refractory angina revisited: stem cells for a growing unmet clinical need? (2018) (1)
- MicroRNAs as novel peripheral markers for suicidality in patients with major depressive disorder (2022) (1)
- Abstracts of the 6th Cachexia Conference, Milan, Italy, December 8–10, 2011 (Part 2) (2012) (1)
- MicroRNA-146a regulates angiogenesis and functional regeneration after myocardial infarction (2020) (1)
- Towards novel theranostic approaches in cardiac transplantation medicine. (2014) (1)
- A new diastolic dysfunction disease-modelling platform. (2019) (1)
- Antiageing concepts and cardiovascular disease. (2015) (1)
- Announcement: Heterocellular signalling and crosstalk in the heart in ischaemia and heart failure (2013) (1)
- Erythropoietin in kidney disease and type 2 diabetes. (2011) (1)
- LINCing MALAT 1 and Angiogenesis (2014) (1)
- Hypoxia-induced long non-coding RNA Malat1 is dispensable for renal ischemia/reperfusion-injury (2018) (1)
- Abstract 114: Safety And Efficacy Of CDR132L, A Novel Antisense Therapeutic Which Targets MicroRNA-132 In Heart Failure Patients (2021) (1)
- Response to Letter Regarding Article, “Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension” (2009) (1)
- Using “old” medications to fight new COVID-19: Re-purposing with a purpose (2020) (1)
- AAV capsid engineering identified two novel variants with improved in vivo tropism for cardiomyocytes. (2022) (1)
- P2308Natural compound library screen identifies potent molecules with anti-fibrotic activity through modulation of noncoding RNAs (2017) (1)
- Annual Meeting of the American Heart Association (2006) (1)
- Abstract 553: Inhibition of Microrna-21 Prevents Myocardial Remodelling and Dysfunction in a Pig Model of Ischemia/reperfusion Injury (2018) (1)
- Enhancer AVE9488 After Experimental Myocardial Infarction Improvement in Left Ventricular Remodeling by the Endothelial Nitric Oxide Synthase (2008) (1)
- Abstract 486: Targeting Bone Marrow Endothelial Nitric Oxide Synthase (eNOS) by the eNOS Enhancer AVE9488 Increases Circulating Endothelial Progenitor Cells After Myocardial Infarction (2006) (0)
- A long way for microRNAs to become meaningful prognostic biomarkers (2018) (0)
- Abstract 19048: Tissue-Specific Regulation of Phospholipase C Beta-3 by Asymmetric Dimethylarginine (ADMA) (2010) (0)
- Diagnostic value of circulating microRNAs compared to high-sensitivity troponin T for the detection of non-ST-segment elevation myocardial infarction (2021) (0)
- Abstract 2963: Circulating Endothelial Progenitor Cells in Patients with Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension (2007) (0)
- Accelerating developments in heart failure. (2022) (0)
- Dichotomy between the transcriptomic landscape of naturally versus accelerated aged murine hearts (2020) (0)
- Abstract P2063: Circular RNA, circREGEN, Alters Cardiac Regeneration Through Cardiomyocyte Proliferation and Regulation of Oxidative Stress (2022) (0)
- Vascular Smooth Muscle Cell Remodeling. (2018) (0)
- Leveraging clinical epigenetics in heart failure with preserved ejection fraction: a call for individualized therapies. (2021) (0)
- Abstract 413: Different Effects Of Organic Nitrates On Endothelial Progenitor Cell Mobilisation And Endothelial Function In Patients With Established Coronary Artery Disease (2008) (0)
- P393miR-1: a link between SERCA2a and the Beta-Adrenoceptor in the failing heart? (2014) (0)
- Musashi-2 causes cardiac hypertrophy and heart failure by inducing mitochondrial dysfunction through destabilizing Cluh and Smyd1 mRNA (2023) (0)
- MicroRNA-1202 Is a Candidate Biomarker To Assist Selection of Patients for Therapy With a Left Ventricular Assist Device (2014) (0)
- MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2017) (0)
- 584 Diminished endothelial progenitor cell mobilisation from bone marrow after acute large myocardial infarction: Differential stimulation by ACE inhibition or statin treatment (2005) (0)
- PO4-10THE EFFECT OF ORTHOTOPIC LIVER TRANSPLANTATION ON MIR-21, LEPTIN AND GENE-METHYLATION PATTERNS IN PATIENTS SUFFERING FROM ETHYL TOXIC LIVER CIRRHOSIS: A PILOT STUDY (2017) (0)
- Th-W52:5 Age-dependent impairment of endothelial progenitor cells is corrected by growth hormone mediated increase of insulin-like growth factor-1 (2006) (0)
- Abstract 873: Differential Effects of Long-Acting Nitrates on Endothelial Progenitor Cells are Determined by Reactive Oxygen Species Formation (2006) (0)
- Characterisation of extracellular vesicles in the context of myocardial infarction and glucose intolerance (2021) (0)
- Restoration of endothelial nitric oxide bioavailability in myocardial endothelial cells treated with dexamethasone (2012) (0)
- P1178 : Micrornas in serum and bile of patients with primary sclerosing cholangitis and/or cholangiocarcinoma (2015) (0)
- Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2018) (0)
- Therapeutic Telomerase Reactivation for the Prevention of Doxorubicin‐Induced Cardiotoxicity (2019) (0)
- STAT 3-mediated regulation of miR-199 a-5 p links cardiomyocyte and endothelial cell function in the heart : A key role for ubiquitin-conjugation enzymes (2010) (0)
- Abstract 3830: MicroRNA-21 Derepresses MAPkinase-Signaling and its Antagonism Prevents Cardiac Failure (2008) (0)
- SuO022MICRORNA-21 AS THERAPEUTIC TARGET IN DIABETIC NEPHROPATHY (2015) (0)
- Circulating miR-1254 predicts ventricular remodeling in patients with ST-Segment-Elevation Myocardial Infarction: A cardiovascular magnetic resonance study (2018) (0)
- Non-coding RNAs in the Vasculature (2017) (0)
- TWIST-1 and Its Target, the miR 199/214 Cluster, Are Down-Regulated in Dilated Cardiomyopathy Resulting in Increased Proteasome Activity in Human Myocardium (2011) (0)
- Reply: To PMID 24913549. (2015) (0)
- Editorial [Hot topic: MicroRNAs: from Basic Regulation Towards Therapeutic Approaches - Passion, Caution and Patience Required (Guest Editor: Dr. Thomas Thum)] (2010) (0)
- Dependent Mechanism Progenitor Cell Function in Patients With Coronary Artery Disease Through a Short Communication : Asymmetric Dimethylarginine Impairs Angiogenic (2010) (0)
- SP123MICRO-RNA REGULATED NEPHRONECTIN IS IMPORTANT FOR PODOCYTES AND GLOMERULAR BASEMENT MEMBRANE INTERACTIONS (2016) (0)
- The role of circular RNA, circREGEN, in cardiac regeneration (2022) (0)
- Toxicogenomics Applied to Cardiovascular Toxicity (2005) (0)
- RNA-binding motif protein 38 inhibits re-endothelialization following vascular injury (2013) (0)
- Paracrine crosstalk between hypoxic cardiomyocytes and cardiac fibroblasts via extracellular vesicles (2015) (0)
- The miRNA-193B is a potent tumor-suppressor and a biomarker for poor prognosis in acute myeloid leukemia (2017) (0)
- Controls Cardiac Hypertrophy by Combined Repression of Mitogen-Activated (2013) (0)
- 347 A validated method for the determination of epoxyeicosatrienoic acids (EETS) using high performance liquid chromatography — electrospray ionisation/mass spectrometry (HPLC-ESI/MSN) (2003) (0)
- Novel models and mechanisms of heart failure with preserved ejection fraction (2016) (0)
- OP-EHEA200791 1..10 (2020) (0)
- We-P11:32 Uncoupled endothelial nitric oxide synthase in diabetic bone marrow-impact on endothelial progenitor cells (2006) (0)
- MiR-21 mediates interstitial fibrosis in cardiac allograft by supporting monocyte to fibroblast transition (2013) (0)
- Abstract 195: TIP30 Interferes With Protein Synthesis And Inhibits Cardiac Hypertrophy (2013) (0)
- Neonatal injury models: integral tools to decipher the molecular basis of cardiac regeneration (2022) (0)
- FC018 HIGH DIETARY PHOSPHATE INTAKE AND INTRA-CARDIAC SYNTHESIS OF FIBROBLAST GROWTH FACTOR 23 SYNERGISTICALLY WORSEN CARDIAC FUNCTION FC019 PROTEOMIC PROFILING OF GLOMERULI FROM KIDNEYS WITH HYPERTENSIVE NEPHROPATHY REVEALS SIGNATURE OF DISEASE PROGRESSION (2021) (0)
- Longitudinal characterization of clinically relevant haemodynamics in conscious Ossabaw pigs with HFpEF (2022) (0)
- Activation of stress response signaling rewires cardiac metabolism in Barth syndrome (2022) (0)
- Cardiac myocyte miR-29 promotes pathological remodeling of the heart by activating Wnt signaling (2017) (0)
- The Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Germany. (2020) (0)
- Abstract 477: Platelet microRNAs Crosstalk with Vascular Endothelial Cells in Diabetes (2018) (0)
- Abstract 11441: Musclin, a Novel Skeletal Muscle Derived Myokine, Attenuates LV Dysfunction and Myocardial Fibrosis During Cardiac Cachexia (2018) (0)
- miRNAs involved in the generation, maintenance, and differentiation of pluripotent cells (2012) (0)
- Dichotomy between the transcriptomic landscape of naturally versus accelerated aged murine hearts (2020) (0)
- Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212 (2019) (0)
- 199 Takotsubo syndrome associated mir-16 and mir-26a reduce contractility of cardiomyocytes in vitro by an inhibitory g-?protein dependent mechanism (2017) (0)
- Correction to: Non-coding RNAs in the Vasculature (2019) (0)
- Recent patents on stem cell transplantation in cardiovascular medicine. (2007) (0)
- MicroRNA-483-3p is upregulated in circulating plasma and ventricular myocardium after therapy with a left ventricular assist device (2014) (0)
- Aldosterone mediated dysfunction of human endothelial progenitor cells - Mechanisms and therapeutic opportunities. (2007) (0)
- P153MicroRNAs involved in cardioprotection by ischemic pre- and postconditioning: ProtectomiRs (2014) (0)
- The Janus Face of miR-148a in Cardiac Remodeling and Heart Failure. (2019) (0)
- Aging causes alveolar epithelial type II cell dysfunction in acute lung injury (2020) (0)
- 341 Microarray analysis reveals complex deregulation of gene expression in heart tissue upon aroclor 1254 treatment-implications for cardiotoxicity (2003) (0)
- Anti-miR and gene therapy to heal the diseased heart (2017) (0)
- FC 018HIGH DIETARY PHOSPHATE INTAKE AND INTRA-CARDIAC SYNTHESIS OF FIBROBLAST GROWTH FACTOR 23 SYNERGISTICALLY WORSEN CARDIAC FUNCTION (2021) (0)
- Blood biomarkers in Takotsubo syndrome point to an emerging role for inflammaging in disease pathophysiology (2023) (0)
- Absence of microRNA‐155 protects against pressure overload‐induced cardiac inflammation and failure (2012) (0)
- MicroRNAs in the pathogenesis of RV remodelling (2017) (0)
- Abstract 11898: Lysyl-Oxidase Mediated Regulation of Mir-21 and Spry1 Contributes to Strcutural Remodeling During Atrial Fibrillation (2011) (0)
- FP280FUNCTIONAL INVESTIGATION OF MIR-17-5P INHIBITION IN KIDNEY ISCHEMIA-REPERFUSION INJURY IN MICE (2019) (0)
- MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation (2022) (0)
- Abstract 19973: Takotsubo Syndrome Associated miR-16 and miR-26a Reduce Contractility of Apical, but Not Basal, Cardiomyocytes in vitro (2017) (0)
- 343 Oxidized LDL is a major regulator of metabolic pathways in human endothelial cells (2003) (0)
- MicroRNA-Mediated Regulation of Cardiovascular Differentiation and Therapeutic Implications (2015) (0)
- Debating new strategies for cardiac protection in the ageing heart in Naples, Italy: News from the joint meeting of the ESC Working Groups of Myocardial Function and Cell Biology of the Heart. (2020) (0)
- DependentSHuman Endothelial Cells : Involvement of LDL Cholesterol Upregulates Synthesis of Asymmetrical Dimethylarginine (2000) (0)
- Malfunction of endothelial progenitor cells and endothelial function in patients with Fabry disease. (2007) (0)
- 34 Proteomic and micro rna biomarker discovery to identify novel markers of left ventricular diastolic dysfunction in patients with diabetes (2017) (0)
- Transforming growth MicroRNA-Mediated Epigenetic Silencing of Sirtuin1 Contributes to Impaired Angiogenic Responses Short Communication (2013) (0)
- Proceedings 7th International Workshop on Formal Methods and Analysis in Software Product Line Engineering (2016) (0)
- Overexpression of preeclampsia induced microRNA-26a-5p leads to proteinuria in zebrafish (2018) (0)
- ASSESSMENT OF ENDOTHELIAL FUNCTION, NUMBERS OF CIRCULATING ENDOTHELIAL PROGENITOR CELLS, SOLUBLE ADHESION MOLECULES AND SERUM LEVELS OF INFLAMMATORY MARKERS SUGGEST THE ABSENCE OF RELEVANT ENDOTHELIAL DYSFUNCTION IN CONTEMPORARY PATIENTS WITH REPAIRED COARCTATION (2010) (0)
- FO023ASYMMETRIC DIMETHYLARGININ INDUCES ENDOTHELIAL DYSFUNCTION VIA MODULATION OF MICRORNA 126 (2015) (0)
- YI-807 ENHANCED SYSTEMIC NO BIOAVAILABILITY BY GROWTH-HORMONE MEDIATED IGF-1 INCREASE IMPROVES NUMBER AND FUNCTION OF ENDOTHELIAL PROGENITOR CELLS IN AGED INDIVIDUALS (2007) (0)
- Telomerase as a therapeutic target for cardiac protection and regeneration (2022) (0)
- Identification of Gene Expression Signatures for Phenotype-Specific Drug Targeting of Cardiac Fibrosis (2023) (0)
- Announcement: Heterocellular signalling and crosstalk in the heart in ischaemia and heart failureto be published in May, 2014 (2013) (0)
- P5384LNA-based miR132 inhibition is cardioprotective in a pig model of percutaneous transverse aortic constriction (pTAC) (2017) (0)
- Preservation of Relevant Signaling Pathways in the Living Precision Cut Lung Slices of Patients With Pulmonary Fibrosis (2023) (0)
- COVID-19: Insights into long-term manifestations and lockdown impacts (2023) (0)
- OriginalClinicalScienceçGeneral MicroRNA 628-5 p as a Novel Biomarker for Cardiac Allograft Vasculopathy (2016) (0)
- MicroRNA-155 promotes acute cardiac allograft rejection in human and mice (2013) (0)
- SP044MICRO-RNA REGULATED INTERACTIONS BETWEEN PODOCYTES AND GLOMERULAR BASEMENT MEMBRANE IN PROTEINURIC KIDNEY DISEASES (2015) (0)
- Supplemental Material (2004) (0)
- Summary of basic science activities at the European Society of Cardiology Congress in Barcelona 2014 (2014) (0)
- Orchestration of vascular smooth muscle cell plasticity using epigenetic therapy. (2022) (0)
- 460 Best Posters in metabolic syndrome, obesity and nutrition / Best Posters in cardiac remodelling P2306 | BEDSIDE Impact of gender difference on abdominal fat accumulation and coronary artery disease severity stratified by computed tomography-derived SYNTAX score (0)
- SP122MIR-143 DEPENDENT DOWNREGULATION OF PODOCYTIC AND ENDOTHELIAL GLYCOCALYX PROTEINS CAUSES PROTEINURIA (2016) (0)
- 381 Cytochrome P450 gene expression and protein activity in bronchoalveolar macrophages and bronchial epithelial cells of smokers and non-smokers (2003) (0)
- Abstract 254: Growth Hormone Treatment of Healthy Middle-aged Volunteers Improves Nitric Oxide Bioavailability and Circulating Endothelial Progenitor Cell Levels via Insulin-like Growth Factor-1 (2007) (0)
- The role of surfactant protein D in fibrotic lung remodelling (2014) (0)
- ew Insight Into ealing Mechanisms f the Infarcted Heart (0)
- Abstract 16458: Paracrine Crosstalk Between Paltelets And Vascular Endothelial Cell is Mediated via MicroRNAs (2015) (0)
- SP175SOURCE AND FUNCTION OF MIR-17 IN MURINE KIDNEY ISCHEMIA-REPERFUSION INJURY (2016) (0)
- SO005TRANSLATION OF ANTI FIBROTIC MICRORNA STRATEGIES INTO A MOUSE MODEL OF CHRONIC ALLOGRAFT DYSFUNCTION (2016) (0)
- Preclinical development of a miR-132 inhibitor for heart failure treatment (2020) (0)
- Increased serum levels of regenerative miRNAs in patients with spontaneous recovery from acute liver failure (2015) (0)
- Circular RNAs at the intersection of cancer and heart disease: potential therapeutic targets in cardio-oncology. (2023) (0)
- Circulating Long Noncoding RNA TrAnscript Predicting Survival in AKI Is a Predictor of Mortality in Critically Ill Patients with Acute Kidney Injury (2014) (0)
- Cardiovascular Disease Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of (2011) (0)
- Induced Vascular Injury : Therapy Through LOX-1 Receptor Antagonism ? − Lipoprotein Mechanistic Role of Cytochrome P 450 Monooxygenases in Oxidized Low-Density (2003) (0)
- The ESC Working Group on Myocardial Function. (2020) (0)
- 338 Doxorubicin treatment leads to repression of certain transcription factors in rat hearts: A microarray gene expression study in aid for hypothesis generation (2003) (0)
- 185 Glycoproteomics Reveals Decorin Peptides with Anti-Myostatin Activity In Human Atrial Fibrillation (2016) (0)
- Publisher Correction: MicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure (2018) (0)
- miRNA-132 inhibition prevents fibrosis and hypertrophy in a pig model of percutaneous transverse aortic constriction (pTAC) (2016) (0)
- Gene Therapy and Cardiovascular Diseases. (2023) (0)
- MicroRNA Target Sites as Genetic Tools to Enhance Promoter-Reporter Specificity for the Purification of Pancreatic Progenitor Cells from Differentiated Embryonic Stem Cells (2012) (0)
- A single session of EMS training induces long-lasting changes in circulating muscle but not cardiovascular miRNA levels - A randomized crossover study. (2023) (0)
- Abstract 5390: The Endothelial Nitric Oxide Synthase Enhancer AVE9488 Increases Circulating Endothelial Progenitor Cells and Prevents Heart Failure Early after Myocardial Infarction (2008) (0)
- Abstract 687: Paracrine Function of Extracellular microRNA-191 in Diabetes Associated Impaired Wound Healing (2015) (0)
- CIRCULATING MICRORNAS AS MEDIATORS IN CELL-TO-CELL 1 COMMUNICATION (2020) (0)
- MicroRNA-22 increases senescence and activates cardiac fibroblasts in the aging heart (2012) (0)
- A06 Novel Steroid-Based Strategy to Restore Blood Brain Barrier Integrity and combat Tissue Edema after Ischemic Brain Injury (2012) (0)
- Deciphering Pro-angiogenic Transcription Factor Profiles in Hypoxic Human Endothelial Cells by Combined Bioinformatics and in vitro Modeling (2022) (0)
- Glucocorticoid signalling and resistance at the blood–brain barrier in central nervous system disorders (2012) (0)
- Hypoxic preconditioning of macrophages as therapeutic strategy for ischemic cardiac injury (2022) (0)
- Reply (2015) (0)
- Abstract 1691: Atorvastatin Treatment reduces Vascular Oxidative Stress and improves Endothelial Dysfunction in Streptozotocin-induced Diabetes Mellitus by increasing the Expression of GTP-Cyclohydrolase I (2006) (0)
- Skeletal muscle derived Musclin protects the heart during pathological overload (2022) (0)
- Alveolar Epithelial Type II Cell Function in Acute Lung Injury Is Impaired in Old Mice (2020) (0)
- Leukocyte telomere length correlates with hypertrophic cardiomyopathy severity (2018) (0)
- MicroRNA 628-5p as a Novel Biomarker for Cardiac Allograft Vasculopathy (CAV).: Abstract# D2348 (2014) (0)
- Key Words : heart failure ◼ microRNA ◼ myocardial infarction MicroRNAs in Myocardial Infarction (2013) (0)
- An exploratory approach to identify microRNAs as circulatory biomarker candidates for epilepsy-associated psychiatric comorbidities in an electrical post-status epilepticus model (2023) (0)
- Chemical and mechanical activation of resident cardiac macrophages in the living myocardial slice ex vivo model (2022) (0)
- MicroRNA profiling in humans and mice identifies microRNA-155 as a key regulator of acute cardiac allograft rejection (2014) (0)
- Abstract 206: A New MicroRNA Family Regulating Cardiac Autophagy and Hypertrophy (2012) (0)
- Optimization of the On-site Transportation Logistics of a Chemical Factory using Multi-Agent Systems (2000) (0)
- Deficiency: FERRIC-HF: A Randomized, Controlled, Observer-Blinded Trial Nonanemic Patients With Symptomatic Chronic Heart Failure and Iron Effect of Intravenous Iron Sucrose on Exercise Tolerance in Anemic and (2011) (0)
- MicroRNAs: from basic regulation towards therapeutic approaches--passion, caution and patience required. (2010) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Thomas Thum?
Thomas Thum is affiliated with the following schools:
